Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial (Q36614123)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2006
edit
Language Label Description Also known as
English
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
scientific article published on April 2006

    Statements

    Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial (English)
    J Cassidy
    J-Y Douillard
    J J McKendrick
    W Scheithauer
    I Bustová
    P G Johnston
    K Lesniewski-Kmak
    S Jelic
    F Coxon
    E DĂ­az-Rubio
    T S Maughan
    A Malzyner
    A Beham
    A Figer
    P Dufour
    K K Patel
    W Cowell
    L P Garrison
    1 April 2006
    1122-1129

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit